2014 علم المناعة (1)
TRANSCRIPT
-
1
I I1I
(prcurseurs)
I
TT I
BB
-
2
I
TBT
T I1
T
TB
-
3
I2
.
T BCPA TB
TB
I II:
PayerLamina propia Amygdales
-
4
II 1- II
II
m%.
m2%
m%1
II Mastocytes
IImonocytes(macrophages)
m%lysosomes ( m
-
5
-mylode lymphode
(mylodes)(lymphodes)T
II
II
-
6
Scavenger
II Toll Like Receptors: TLRTollTollToll
(infection)TLRTLR
chimiokines CD80B7- 1CD86B7- 2
Toll II
TB IIBT
mmm
II1
T) T prT=prcurseurs deT
-
7
Bpr BB
II1 (CD, Classe de diffrenciation) TBT TCD4 TCD8
8T4TB
II1Ag, antigneB(B cell receptor
B IgM IgD
B
(B cell receptor BCR T cell receptor TCR
-
8
TTCR ,T cell receptor NH2%
TTCR/TCR /TCR/%
II13TNKTNKTTCRCD3T NKNKTTCR
1CMHCD1d
2-2-II
% %
% %
% %
% %
3-2-II
(B, T) . 24
. .
-
9
II 4 m
lymphoblastem
-
10
I
I :(la peau)
(les muqueuses) :
I
lysosyme
NaCl
pH
I
(la flore)LactobacillespH
II
-
11
(exsudation plasmatique) oedme
- (diapdse)
III
IL
IL6IL12Tumor
TNFchimiokinesIL8MCP-1
III1CyotkinesIII1 1 III111
TNFslectinesPE
-
12
-
IL8MCP-1Integrines
-
-
13
ICAM-1 ICAM-2InterCellular Adhesion Molecule
III112recrutement IL8
MCP-1
IL8TNF
III113Phagocytose
-
14
NN
chimiokinesC5aC3a
-(particule)
pneumocoqueMstreptocoques
-
- Espces oxygnes ractives
O2ion superoxyde-
-
15
H2O2 l oxygne singuletO2 OH
PHPH 4
--myloperoxydase-
L- arginineL- citrulline NO synthaseNADPH O2
L- arginine + L- citrulline
NO (prcurseur) NO2NOOONO
-
Phagolysosome
Lysosyme
neutrophilesmacrophages
CRP . MBL
III 2- 1 TNFIL1 IL6pyrognes
-IL1 IL6TNF C (CRP : C- reactive protein)
) (MBP :Mannose binding protein( MBL :Mannan binding lectin AD
NO syntase O2, NADPH
1
-
16
-
IV
1-IV Le complement:
1-1-IV
monocytes-macrophages
2-1-IV
, C8, C7 , C6, C5, C3 ,C2, C4,C1C9
CRPC C9, C8, C7 , C6, C5, C3 ,C2, C4,C1Mannan
Binding LectinMBL
MBL C4MBLC1q C1
MASP1MASP2Associated Serine ProteasesMBL
C1sC1r C1MBLMASP1MASP2
C4C2
-
17
MBL
- B D
(C9,C8, C7 , C6, C5, C3
1-2-1-IVVoie classique :
Ag-Ac
C1C1s,C1r,C1qC1Ag-Ac
C1q FcIgG IgMC1q
C1rC1rC1sC1s
C1sC4Mg
C4aC4bPathogneC2
C1s C2bC2aC2aSerine protease
C4bC2a C3 la C3 convertase C4b2a
C3C3a C3bC3bAg-
AcC3 C4b2a C4b2a3b C5)C5 convertase(
AgAg-AcC5C5aC5b
-
18
(C4b2a) C3C3
MAC
C5bAgAg-Ac C8,C7,C6 C9
C5bC6C7C8C9
-2-1-IV 2Voie alterne :
C3C3H2oBD
C3H2oBBaC3C3H2oBb(C3 convertase initiale)C3
C3bC3a
C3bBD
C3 C3bBbC3 convertase alterne C3
C3b C5 (C5 convertase
C3H2OBb
-
19
(C3bBb) C3C3H2OBbC3
(C3bBb) C3C3 (C3bBb) C3
C5C3bC5C 3 C3bBb C4b2aC5
-
20
C5C5aC5b
3 -2-1-IV
3 -1-IV Rgulation:
C1 C1INHC1sC1 C1q
C1qC1qINHC1qC1r C1s
(C4bp) C4 binding protein--C4bC4b2aC3 C2
C4bC4bpC4bIC4bC4d C4c
HC3bI C3bC3bi
-
21
HBC3bBbC5 convertaseC3bBb3b
C3b complment receptor 1
.(CR1)HC3b
Vitronectine SClustrineC5b67
(CD5) DAF
C3 C5
rotein) Pofactor Cembrane M( MCP (CD46) C4bC3b
I
DAFMCP
BC3aC5a
-1-IV 4
4-1-IV- (Opsonisation) C3bC4b
OpsonisationOpsonomonocytes
macrophagesC3bC3b
phagocytes
C3b
4-1-IVactivit chimiotactique:
C5aBaC5b67Polynuclaires
4-1-IV
C4a C3aC5amastocytesbasophiles
histamine
-
22
2 -IV (phase aigue)
CRpMBLADserum amyloid proteinSAP
CRPCpneumocoque) C1
CRP (opsonine
MBLCRP
AD (les surfactants pulmonaires)
macrophages
-
23
3 -IV
4-IV
Magainines,Cecropinesdfensines
-
24
V
1-V
NKNatural Killer
NK
NK KAR (Killer activatory receptor)
)(Killer inhibitory receptorKIR KIRCMH1NK
KAR KIR.
CMH1
NKKAR
-
25
NKFc G IgGCD16
IgG NK
NK
NKKAR
CD16perforines
granzymesperforines
(polyperforines)Granzymesprotases
mort progamme ou apoptose
NK/
-
26
2- Vcytolitique
NK Ligand Fas FasCD95
NK/
VApoptose
ADN
(macrophages)
Apoptose
-
27
B
TCD4
TCD8
n
-I
1-I
2-I
:
3-I
(pitopes)
ovalbumine44000=PM69000=PM
-
28
haptnes
4-I
4-I1:
-xnoantigne=htroantigne
Alloantignes
Autoantignes
4-I2 Alloantignes
ABOBA
rhsus D
HLA .(CMH1,CMH2CMH1
CMH2
streptocoqueslancefield
5-I
(rejet de greffe)
Alloantignes
HLA (human leukocyte antigen)
H-2
5-I (CMH)HLA
CMH1CMH2
HLA
-
29
Gerald Karp 2010 Biologie cellulaire et molculaire
-5-I 1 - 1 HLA I
HLA I HLA-C, HLA-B, HLA-A
2 2 microglobuline
5-I HLA II
HLA IIDDQDPDR
) :- DQ ( DQ)DP-) (DP-DR .(DR
-
30
II(DQ, DP, DR)IIB
HLA A1 A3 B5 B8 C4 C6
codominance
CMHIII
HLA II
TAPLMP
Transporter Associated with Processing :TAP
: Large Multifunctional Proteases (protosomes): LMP
5-I HLA
5-I 1- I
HLA I(kd45)2 microglobuline . (kd 12)
CD8TCD8T
2 microglobuline
HLA
-
31
-5-I -2 II
HLA II, ) (non covalente1
12
CD4
5-ICMH
5-I 1T
5-I 1-1-apprtageCMH II
CPA
Cellules Prsentatrices d'Antigne)
protasesD Bcathepsines
CMH II
(htrodimres
II
protases
IIII.CMH
CMH IIT4
-
32
1-3-5-I 2 apprtage CMH I
(endognes)oncognes
ADN
LMP
TAPCMH
ICMH I-TCD8
TAPTransporter Associated with antigen Processing
6 I mitognes
.
phytohmagglutinine (PHA) T nocordia B
II
(chmokines)Fibroblastespithliales
endothliales(cytokines)IL-1
-
33
TT(naves)
TNF IL-1
(dendrites)
CCR7
SLC
Secondary lymphode chemokine (CCL21) endothliales
CMHCMH II
(Co-stimulation)TCD80-86
CD404-1BBL
veinules
endothliales hautes (HEV)(paracortex)T
HEV
-
34
CMH II
TCD4naifs
TCD8T cytotoxiqueTCMH I
TCD4TCR :T cell receptorCMH II
CPACD4CMH II
T8CD8CMH ITCR CMH I
CD4 CD8(corcepteurs)CD3 TCR
TCPALFA1TICAM-1
CPA CD2 T (CD58) LFA3CPA
:Lymphocyte-Function Associated Antigen: LFA1
InterCellular Adhesion Molecule : ICAM -1:
-
35
II TCD4
(T Cell Receptor)TCRCD4 TCD3
(signal 1) (Th0 =)TCD4B7CPA
CD28TCD4(2em
signal)T
T1TCRT
TCD4(IL2-R)IL2 IL2
(IL2)lymphoblaste
CPACD40 CD 40
ligand (CD 152) TCPA(IL12)12
T4 Th1
Th1
IL2 TNF
-
36
TCD4
Th1CTL-A CD80
CD86 CPA T
Th1
-
37
T4
II 2 T4
interfron (INF de type II = )
1 O2
protases,hydrolases
-2 Fc IgGIgGAg
TNF T4
-
38
II (T8) TCD 8
T8allognique
xnogniqueCD8CMH I
CMH I
II T8
CMH1T8
T8naive (costimulation)B7
T8T8IL2
T8 T8 T8 effectricesTTcytotoxiques T8
T8
3 - II T8T4
T8T4CPA
CD40ligandCPA CD40B7
4-1BBL costimulation)(T8
IL2T8T8 (Tc) Tcytotoxiques
T8
-
39
T8 T4
- II 3
Tcperforines serines estrases-granzymes
Tc
Ca++
polyperforines
l'apoptoseTc
Tc/
3 - II
T8Tc) (ligandFasFas
4 - II
T2nCMH
n
-
40
I Antignes thymo-indpendants
I
(BCR) B cell receptor
Ig ,immunoglobulines membranaires
Ig IgkD
(Ag)BCR
BCR Ig ( Ig
IB
B
Tantignes T-dpendants) (
T antignes T-indpendants (BT
T
T
lipopolysacharide 1BCR Ag2 Ag
(mitogne
T
polysaccharide de Pneumococcus flagelline polymrique
.(poliomyliteB
TT
I 3-
-
41
mm
lymphoblaste Plasmocytes
IIT
II 1 -
T
4T
-
42
CD4T
CMHCPAB
II 2-
CPACD4T
T helperBCR
B (Ag-BCR B
CMH-2B T4 effecteur T4. Th
T4 T4 effecteur TCRCMH-2
CD40L BCD40)B
INFIL10IL6IL5IL4IL2B
lymphoblaste(22m.
- II 3
Blymphoblaste
-
43
B
III
1 - III
2- III
III-2 1
IgGGimmunoglobulineG
Light(L PM 25000
Heavy(H)
.Cystine
-
44
L
N-
terminale
CL
VL
H
CDR,complementary determinating regions
-
45
2 - 2 - III
Fab (Fragment antigen binding) L
H
fragment cristalisable Fc
III3
- III 4
IgMmu IgGgammaIgAalfaIgDdelta
IgEepsilon
IgGIgG1,2,3,4IgAIgA1, IgA2
- III 5
IgA
IgM
-
46
IgG 1, 2, 3 4 : IgG
-
47
-
48
6- III
dterminant antignique
paratope
Ac Ag
H
O N
WallsVander
WallsVander
7 - III
1-7-III neutralisation:
Streptolysine Streptokinase IgG IgM IgA
2 -7 -III Opsonisation
-
49
FC
C3b
IgG IgA
3-7-III
C1 C9IgG1,2,3IgM
-
50
-7-IIIADCC
NKFCIgG
perforines granzymes
(ADCC : Antibody Dependant Cellular Cytotoxicity)
IV
1- IV
IgM
2- IV
TB
.
IgG
-
51
-
52
V Immunisation
1 - V
1-1 - V
1-1-1-V
BCG(Bacille de Clamette et Guerin)in vitroMycrobacterium
Tuberculosis
2-1-1-V
o
3-1-1-V inactives
toxineso
anatoxinesanticorps
neutralisants )
4-1-1-V
2-V
-
53
. Ag Ac
I
-I
Ag
-
54
Le ring test
-I
Ouchterlony -
Ouchterlony :
Mancini -
-
55
II- 2
Hmagglutination sur lame
-
56
GRM
(GRM
III
Ac Ag
Farr 1 -III
125I
-
57
2 -IIIImmunofluorescence
fluorescine .(290_495nm)
525nm
-
58
( Enzyme Linked Immuno Sorbent Assay) ELISA 3-III
-
VIH
PNPP : paranitrophenyl phosphate